Transgene SA TRGNF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.22% | -9.03% | -15.28% | -32.98% | -61.58% |
| Total Depreciation and Amortization | 7.06% | 9.79% | 8.11% | 2.15% | -2.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -86.34% | -83.94% |
| Total Other Non-Cash Items | 188.09% | 221.70% | 233.79% | 115.52% | 93.94% |
| Change in Net Operating Assets | -161.10% | -153.74% | -145.13% | 38.98% | 307.14% |
| Cash from Operations | -79.99% | -76.72% | -64.59% | -4.75% | 34.83% |
| Capital Expenditure | 3.70% | 49.97% | 70.99% | 65.02% | 58.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9,136.13% | -17,952.16% | -80,291.93% | -727.57% | -105.49% |
| Cash from Investing | -3,929.42% | -3,679.29% | -3,462.13% | -1,080.31% | -115.49% |
| Total Debt Issued | -1.50% | -103.00% | -- | -301.50% | -200.00% |
| Total Debt Repaid | 100.00% | 98.72% | 98.63% | 96.42% | 94.85% |
| Issuance of Common Stock | 94,595.50% | 94,595.50% | 94,595.50% | 94,695.50% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -37.52% | 5.14% | 77.66% | 136.13% | 259.93% |
| Cash from Financing | 341.59% | 395.93% | 433.95% | 194.03% | -11.16% |
| Foreign Exchange rate Adjustments | 70.03% | -1,162.61% | -319.22% | -330.44% | -354.69% |
| Miscellaneous Cash Flow Adjustments | 209.09% | 220.00% | -- | -- | -- |
| Net Change in Cash | -1,028.64% | -1,089.51% | -1,174.83% | -174.76% | -87.47% |